首页> 外文期刊>Diabetes >Allele-Specific Transcriptional Activity at Type 2 Diabetes-Associated Single Nucleotide Polymorphisms in Regions of Pancreatic Islet Open Chromatin at the JAZF1 Locus
【24h】

Allele-Specific Transcriptional Activity at Type 2 Diabetes-Associated Single Nucleotide Polymorphisms in Regions of Pancreatic Islet Open Chromatin at the JAZF1 Locus

机译:在JAZF1基因座的胰岛开放染色质区域中与2型糖尿病相关的单核苷酸多态性的等位基因特异性转录活性。

获取原文
获取原文并翻译 | 示例
       

摘要

Translation of noncoding common variant association signals into meaningful molecular and biological mechanisms explaining disease susceptibility remains challenging. For the type 2 diabetes association signal in JAZF1 intron 1, we hypothesized that the underlying risk variants have cis-regulatory effects in islets or other type 2 diabetes-relevant cell types. We used maps of experimentally predicted open chromatin regions to prioritize variants for functional follow-up studies of transcriptional activity. Twelve regions containing type 2 diabetes-associated variants were tested for enhancer activity in 832/13 and MIN6 insulinoma cells. Three regions exhibited enhancer activity and only rs1635852 displayed allelic differences in enhancer activity; the type 2 diabetes risk allele T showed lower transcriptional activity than the nonrisk allele C. This risk allele showed increased binding to protein complexes, suggesting that it functions as part of a transcriptional repressor complex. We applied DNA affinity capture to identify factors in the complex and determined that the risk allele preferentially binds the pancreatic master regulator PDX1. These data suggest that the rsl635852 region in JAZF1 intron 1 is part of a cis-regulatory complex and that maps of open chromatin are useful to guide identification of variants with allelic differences in regulatory activity at type 2 diabetes loci.
机译:非编码常见变体缔合信号转换成有意义的分子和生物学机制,解释疾病易感性仍然具有挑战性。对于JAZF1内含子1中的2型糖尿病关联信号,我们假设潜在的风险变异体在胰岛或其他2型糖尿病相关细胞类型中具有顺式调节作用。我们使用了实验预测的开放染色质区域图,将变体的优先级用于转录活性的功能后续研究。测试了包含2型糖尿病相关变体的12个区域在832/13和MIN6胰岛素瘤细胞中的增强子活性。三个区域表现出增强子活性,只有rs1635852表现出增强子活性的等位基因差异。 2型糖尿病风险等位基因T的转录活性比非风险等位基因C低。该风险等位基因显示与蛋白复合物的结合增加,表明其作为转录阻遏物复合物的一部分。我们应用DNA亲和力捕获来识别复合物中的因素,并确定风险等位基因优先结合胰腺主调节剂PDX1。这些数据表明,JAZF1内含子1中的rs1635852区是顺式调控复合物的一部分,开放染色质图谱可用于指导在2型糖尿病基因座处调控活性具有等位基因差异的变异体的鉴定。

著录项

  • 来源
    《Diabetes》 |2013年第5期|1756-1762|共7页
  • 作者单位

    Department of Genetics, University of North Carolina, Chapel Hill, North Carolina;

    Department of Zoology, Ohio Wesleyan University, Delaware, Ohio;

    Department of Genetics, University of North Carolina, Chapel Hill, North Carolina;

    Department of Genetics, University of North Carolina, Chapel Hill, North Carolina;

    Department of Genetics, University of North Carolina, Chapel Hill, North Carolina;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号